Successful Treatment of Pulmonary Embolus Secondary to Diabetic Ketoacidosis with Tissue Plasminogen Activator

Main Article Content

Arun Agarwal
Mamta Agarwal
Hiren Bhanderi
Vishal Singh Charan

Abstract

A 75-year-old woman with a history of Type 2 Diabetes mellitus attended triage with complaints of nausea, occasional vomit, pain in epigastrium and some vague heaviness in breathing of 4-5 days duration. On her physical examination she had mild tachypnea, peripheral capillary oxygen saturation (SpO2) 92% on room air, and high blood glucose and ketones respectively. She was evaluated and diagnosed to have bilateral submassive pulmonary Thromboemboli.

She was managed with fibrinolytic treatment, Heparin, and supportive treatment along with management of Diabetic Ketoacidosis (DKA). Etiological examinations did not reveal any underlying cause. The contribution of diabetes and its acute complication, DKA, to the development of pulmonary thromboembolism is controversial and is discussed. This case with the presentation of sub-massive pulmonary embolism in a patient of DKA with no underlying cause identified is being reported owing to its rareness.

Keywords:
Diabetic ketoacidosis, pulmonary embolism, tissue plasminogen activator (Alteplase), heparin

Article Details

How to Cite
Agarwal, A., Agarwal, M., Bhanderi, H., & Charan, V. S. (2020). Successful Treatment of Pulmonary Embolus Secondary to Diabetic Ketoacidosis with Tissue Plasminogen Activator. Asian Journal of Medicine and Health, 18(8), 32-36. https://doi.org/10.9734/ajmah/2020/v18i830228
Section
Case Report

References

Pouya Saeedi, Inga Ptersoh, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Research and Clinical Practice. 2019; 157(107843):1-10.

Carl GF, Hoffman WH, Passmore GG, et al. Diabetic ketoacidosis promotes a prothrombotic state. Endocrine Research. 2003;29:73–82.

Turpie AGG. Extended duration of thromboprophylaxis in acutely ill medical patients: Optimizing therapy? Journal of Thrombosis and Haemostasis. 2007;5:5-11.

Bilge Uzmezoglu, Levent Ozdemir, Osman Nuri Hatipoglu, Burcu Ozdemir, Ebru Çakır Edis. A case of massive pulmonary embolism due to diabetic ketoacidosis and hyperhomocysteinemia. Eurasian Journal of Pulmonology. 2014;16:124-6.

Petrauskiene V, Falk M, Waernbaum I, Norberg M, Eriksson JW. The risk of venous thromboemlism is markedly elevated in patients with diabetes. Diabetologia. 2005;48:1017-21.

Prandoni P. Acquired risk factors for venous thromboembolism in medical patients. Hematology (Am Soc Hematol Educ Program). 2005;458–61.

Keenan CR, Murin S, White RH. High risk for venous thromboembolism in diabetics with hyperosmolar state: Comparison with other acute medical illnesses. Journal of Thrombosis and Haemostasis. 2007;5: 1185–1190.

Carr ME. Diabetes mellitus: A hypercoagulable state. Journal of Diabetes and its Complications. 2001;15:44–54.

Catherine Langevin, Caroline Lamarche, Robert Z Bell, Michel Vallee. Presumed paradoxical embolus in a patient with diabetic ketoacidosis. International Journal of General Medicine. 2015;8:297–301.